Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventas Inc (NY: VTR )

62.86 +0.04 (+0.06%)
Official Closing Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ventas Inc

< Previous 1 2 3 4 5 6 Next >
International Game Technology To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Goldman Sachs raised the price target for Duolingo, Inc. (NASDAQ: DUOL) from $109 to $132. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. Duolingo shares rose 0.2% to $148.00 in... 
Via Benzinga
Woodstock For Capitalists
Good Morning Everyone! Regional bank PacWest is up 34% in pre-market after being up 81% Friday. They slashed their dividend to conserve capital. With a 19% short interest on the stock, there is... 
Via Benzinga
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million. 
Via Benzinga
Why Ventas Stock Rallied More Than 10% in April
The REIT moved higher despite some mixed views from analysts. 
Via The Motley Fool
Analyst Expectations for Ventas's Future
Via Benzinga
The Best-Performing REITs In April
When investors consider purchasing real estate investment trusts (REITs), they want to find issues that have performed well recently, perhaps because of improving earnings. Stocks that show strong... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
It's Time for 2 Vital Healthcare Businesses to Shine for Investors
Welltower and Ventas got hammered during the pandemic because of their senior housing assets. That's changing in a big way. 
Via The Motley Fool
A Bullish Sign Appears On Ventas's Chart
Via Benzinga
What 4 Analyst Ratings Have To Say About Ventas
Via Benzinga
The Latest Analyst Ratings for Ventas
Via Benzinga
5 REITs Hitting Higher Highs In February
Five real estate investment trusts (REITs) are successfully kicking off the year 2023, with each reaching higher four- and six-month highs.  While there are no guarantees that the bullish vibe will... 
Via Benzinga
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion. 
Via Benzinga
8 Analysts Have This to Say About Ventas
Via Benzinga
Expert Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation. 
Via InvestorPlace
Ventas Inc. REIT: Relief Rally Gains New Strength
While quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR) is up to a three-month high.  
Via Benzinga
3 Unloved REIT Sectors That Are On Fire
More than 200 publicly traded real estate investment trusts (REITs) across 13 sectors are traded on the stock market, according to the National Association of Real Estate Investment Trusts (Nareit)... 
Via Benzinga
5 Must-Buy REITs for Your January Buy List
Here are five exceptional REITs to buy that happen to offer consistent growth and healthy passive income for long-term investors right now. 
Via InvestorPlace
2 High-Yield Dividend Stocks to Buy Before the End of 2022
These two stocks are positioned for growth in 2023. 
Via The Motley Fool
7 Analysts Have This to Say About Ventas
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings: 
Via Benzinga
These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022
Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global. 
Via Benzinga
This High-Yield Dividend Stock May Finally Be Ready to Start Growing Again
Ventas was hit hard during the early days of the coronavirus pandemic, but it is on the cusp of a recovery. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
From A to Z: All The REITs Hitting New 52-Week Lows This Week
From A to Z: All The REITs Hitting New 52-Week Lows This Week Real estate investment trusts (REITs) — and there are a lot of them — have gone from a New York Stock Exchange favorite to a stock to steer... 
Via Benzinga
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down." 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's trading, 528 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
Upgrades 
Via Benzinga
This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors
SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.